In summary, for the first time, we demonstrated that PPP2R1A mRNA expression level was elevated in high-grade ovarian serous carcinoma, invasive breast carcinoma, melanoma, lung adenocarcinoma, and bladder carcinoma. Here, PPP2R1A is linked to lung adenocarcinoma.